Health Care
Magellan Health (Nasdaq: MGLN) announces fiscal 2019 earnings outlook
Fortune-500 company Magellan Health, Inc. (NASDAQ: MGLN) today announced its fiscal 2019 outlook. The healthcare giant now sees net revenue…
Aphria stock continues to bleed for the second day in a row
Aphria Inc. (NYSE: APHA), which nosedived 23.42% to $6.05 at the end of Monday’s trading session, continued to be in…
GSK reorganization gains steam with Tesaro buyout, sale of Asia unit
The recent spate of cancer drugs securing FDA approval indicates that research and development in the area are progressing rapidly. So,…
Tonix Pharmaceuticals skyrockets on additional details of a Phase 3 trial
Tonix Pharmaceuticals (Nasdaq: TNXP) stock skyrocketed during Thursday’s trading session after the pharma company announced additional details of its Phase…
Bayer looks at global lay-offs and divestments post Monsanto acquisition
German drugmaker Bayer (Frankfurt:BAYGn) on Thursday announced the divestment of many businesses, about 12,000 layoffs and $3.8 billion in impairments.…
CVS-Aetna merger promises a new dawn for healthcare sector
The healthcare sector this week witnessed the coming together of two leading players, under a merger deal that stands out…
2018 was the year of healthcare IPOs. Here is why
There were quite a few blockbuster IPOs this year, mostly by tech firms, including Spotify (SPOT), Dropbox (DBX), Elastic (ESTC)…
GW Pharma Q4 results fails to impress the street
GW Pharmaceuticals plc (Nasdaq: GWPH) stock was down about 4% in the extended hours of trading after the company missed…
Earnings preview: GW Pharmaceuticals’ cannabis-based drug to play a major role in the future
The UK-based GW Pharmaceuticals (Nasdaq: GWPH) is set to report its fourth quarter and fiscal 2018-end results for the period…